Back
HCI Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
45
HCI
HCI Group
Last Price:
92.10
Seasonality Move:
6.2%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
243.99
Seasonality Move:
20.36%
Sell
45
HCI Group (HCI)
is a Sell
Is HCI Group a Buy, Sell or Hold?
- The current HCI Group [HCI] share price is $91.51. The Score for HCI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- HCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HCI Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
HCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.97 | Sell |
| Relative Strength Index (14 RSI): | 31.69 | Sell |
| Chaikin Money Flow: | -36942 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (92.62 - 98) | Sell |
| Bollinger Bands (100): | (95.18 - 112.82) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.83 | Buy |
| Relative Strength Index (14 RSI): | 90.67 | Buy |
| Chaikin Money Flow: | -365678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.21 - 198.95) | Buy |
| Bollinger Bands (100): | (137.63 - 173.99) | Buy |
HCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.84 | Sell |
| 20-day SMA: | 94.53 | Sell |
| 50-day SMA: | 102.23 | Sell |
| 200-day SMA: | 89.05 | Buy |
| 8-day EMA: | 92.11 | Sell |
| 20-day EMA: | 94.64 | Sell |
| 50-day EMA: | 99.27 | Sell |
| 200-day EMA: | 90.91 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 198.72 | Buy |
| 20-day SMA: | 171.59 | Buy |
| 50-day SMA: | 157.67 | Buy |
| 200-day SMA: | 165.81 | Buy |
| 8-day EMA: | 210.85 | Buy |
| 20-day EMA: | 183.04 | Buy |
| 50-day EMA: | 165.87 | Buy |
| 200-day EMA: | 167.34 | Buy |
HCI Group Earnings Growth & HCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.24 per share, an increase next quarter of $1.80 per share, an increase this year of $6.46 per share, and an increase next year of $0.25 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
HCI Group Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||